Related Experiment Videos
Randomised trial comparing expectant with medical management for first trimester miscarriages.
S Nielsen1, M Hahlin, J Platz-Christensen
1Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Göteborg University, Sweden.
British Journal of Obstetrics and Gynaecology
|August 24, 1999
Summary
Outpatient treatment using mifepristone and misoprostol for miscarriage did not significantly improve complete miscarriage rates compared to expectant management. Recovery time was slightly longer with medical treatment, with no differences in pain, bleeding, or satisfaction.
Area of Science:
- Reproductive Medicine
- Pharmacological Interventions
- Women's Health
Background:
- First-trimester miscarriages are common and can be managed expectantly or surgically.
- Pharmacological management using antiprogesterone and prostaglandin analogues is an alternative treatment option.
Purpose of the Study:
- To compare the efficacy of mifepristone and misoprostol versus expectant management for outpatient treatment of miscarriages.
- To evaluate if pharmacological treatment increases the rate of complete miscarriage.
Main Methods:
- A randomized controlled trial involving 122 women with first-trimester miscarriages.
- Participants were assigned to either mifepristone/misoprostol or expectant management.
- Surgical evacuation was performed if retained products of conception were detected via ultrasound.
Main Results:
- Complete miscarriage rates were 82% for pharmacological treatment and 76% for expectant management.
- Convalescence time was 1.8 days longer in the pharmacological group.
- No significant differences were observed in pain, bleeding, complications, or patient satisfaction between groups.
Conclusions:
- Outpatient treatment with mifepristone and misoprostol did not significantly increase complete miscarriage rates compared to expectant management.
- Most spontaneous incomplete miscarriages resolve without intervention.
- The combination therapy did not offer a clinically important advantage over expectant management for complete miscarriage rates.